Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Myo-Inositol vs Myo-Inositol + Alpha-Lactalbumin in PCOS
NCT07629895Not yet recruiting
- Sponsor
- Quaid-e-Azam Medical College
- Start
- Sep 2026
- Primary completion
- Apr 2027
- Countries
- 1
01
Overview
Randomised trial of alpha-lactalbumin in polycystic ovary syndrome (PCOS) (2 arms), sponsored by Quaid-e-Azam Medical College. Primary endpoints: Spontaneous Conception Rate at 12 weeks and Achievement of Menstrual Regularity at 12 weeks. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
alpha-lactalbumin
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT07629895.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07629895.